中信證券(06030.HK)委任劉小萌為授權代表
格隆匯2月11日丨中信證券(06030.HK)公佈,2020年2月11日,公司董事會會議審議通過《關於授權董事長代為履行董事會祕書職責的議案》,同意在公司第七屆董事會第一次會議已聘任的董事會祕書王俊鋒先生(擬)獲得董事會祕書任職資格並完成上海證券交易所審核前,授權公司董事長張佑君先生代為履行董事會祕書職責。
審議通過《關於聘任證券事務代表的議案》,同意聘任楊寶林先生擔任公司證券事務代表(擬)。
審議通過《關於變更公司祕書及授權代表的議案》,同意委任劉小萌女士為公司授權代表並委任劉小萌女士及餘曉君女士為聯席公司祕書,均自董事會審議通過之日起生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.